(LOSS) INCOME PER COMMON SHARE (Tables)

12 Months Ended

Dec. 31, 2018

(LOSS) INCOME PER COMMON SHARE

Schedule of the calculation for basic and diluted income per common share

	Year Ended December 31,
	2018		2017		2016
Numerator:
Net (loss) income attributable to Diplomat Pharmacy, Inc.	$	(302,269)	$	15,510	$	28,273
Denominator:
Weighted average common shares outstanding, basic		74,244,520		68,130,322		65,970,396
Weighted average dilutive effect of stock options, RSAs and RSUs		—		649,731		1,739,750
Weighted average dilutive effect of contingent consideration		—		—		337,577
Weighted average common shares outstanding, diluted		74,244,520		68,780,053		68,047,723
(loss) income per common share:
Basic	$	(4.07)	$	0.23	$	0.43
Diluted	$	(4.07)	$	0.23	$	0.42

Schedule of weighted average effect of shares were excluded from the computation of weighted average diluted shares outstanding

	Year Ended December 31,
	2018	2017	2016
Service-based and earned performance-based stock options	4,147,027	3,242,919	1,542,064
Performance-based stock options	574,138	770,503	291,277
Weighted average service-based RSUs	325,469	21,623	—
Weighted average performance based RSUs	1,372,927	—	—
Weighted average RSAs	20,393	10,038	475
Total	6,439,954	4,045,083	1,833,816